nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antibodies for angiogenesis inhibition, vascular targeting and endothelial cell transcytosis
|
Trachsel, Eveline |
|
2006 |
82-83 |
5-6 |
p. 735-754 20 p. |
artikel |
2 |
Antibody production
|
Birch, John R. |
|
2006 |
82-83 |
5-6 |
p. 671-685 15 p. |
artikel |
3 |
Application and potential limitations of animal models utilized in the development of trastuzumab (Herceptin®): A case study
|
Pegram, Mark |
|
2006 |
82-83 |
5-6 |
p. 723-734 12 p. |
artikel |
4 |
Current and future issues in the manufacturing and development of monoclonal antibodies
|
Kozlowski, Steven |
|
2006 |
82-83 |
5-6 |
p. 707-722 16 p. |
artikel |
5 |
Editorial Board
|
|
|
2006 |
82-83 |
5-6 |
p. ii- 1 p. |
artikel |
6 |
Engineered antibody therapeutics
|
Mather, Jennie P. |
|
2006 |
82-83 |
5-6 |
p. 631-632 2 p. |
artikel |
7 |
Engineering of therapeutic antibodies to minimize immunogenicity and optimize function
|
Presta, Leonard G. |
|
2006 |
82-83 |
5-6 |
p. 640-656 17 p. |
artikel |
8 |
Formulation and delivery issues for monoclonal antibody therapeutics
|
Daugherty, Ann L. |
|
2006 |
82-83 |
5-6 |
p. 686-706 21 p. |
artikel |
9 |
Latest technologies for the enhancement of antibody affinity
|
Wark, Kim L. |
|
2006 |
82-83 |
5-6 |
p. 657-670 14 p. |
artikel |
10 |
Natural IgM antibodies: The orphaned molecules in immune surveillance
|
Vollmers, H. Peter |
|
2006 |
82-83 |
5-6 |
p. 755-765 11 p. |
artikel |
11 |
Therapeutic antibodies — Delivering the promise?
|
Hale, Geoff |
|
2006 |
82-83 |
5-6 |
p. 633-639 7 p. |
artikel |